TREATS Act
Sponsored By: Senator Murkowski, Lisa [R-AK]
Introduced
Summary
This bill would authorize telehealth evaluations for certain substance use disorder prescriptions. It would add a new "telehealth evaluation" definition to the Controlled Substances Act and allow two-way audio-only or audio-plus-video telehealth consistent with the Social Security Act telehealth framework.
Show full summary
- People with substance use disorder: Would allow a telehealth evaluation to be used as part of the prescribing process for FDA‑approved Schedule III, IV, or V medications for treating substance use disorder, in addition to the required in-person evaluation.
- Clinicians (not pharmacists): Would be permitted to perform the telehealth evaluation from a remote location using the two-way real-time telecommunications system described in section 1834(m) of the Social Security Act. Either the distant-site practitioner or the treating practitioner may perform the evaluation.
- Regulators and telehealth services: Creates a statutory definition that ties telehealth evaluations to applicable federal and state laws and anchors allowed telehealth modes to the Social Security Act standard.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Telehealth visits for SUD medications
This bill would let you use one telehealth medical evaluation when getting an FDA-approved Schedule III, IV, or V drug for substance use disorder. You would still need at least one in-person medical evaluation. The telehealth visit could be audio-only or include video. A licensed practitioner (not a pharmacist) must do the telehealth visit. The telehealth visit would have to follow federal and state law and use the two-way system referenced in section 1834(m) of the Social Security Act. This change would take effect upon enactment.
Sponsors & CoSponsors
Sponsor
Murkowski, Lisa [R-AK]
AK • R
Cosponsors
Sen. Whitehouse, Sheldon [D-RI]
RI • D
Sponsored 10/23/2025
Sen. Warner, Mark R. [D-VA]
VA • D
Sponsored 10/23/2025
Sen. Tillis, Thomas [R-NC]
NC • R
Sponsored 10/23/2025
Sen. Kaine, Tim [D-VA]
VA • D
Sponsored 10/23/2025
Dan Sullivan
AK • R
Sponsored 10/23/2025
Sen. Luján, Ben Ray [D-NM]
NM • D
Sponsored 10/23/2025
Sen. Cortez Masto, Catherine [D-NV]
NV • D
Sponsored 10/23/2025
Sen. Merkley, Jeff [D-OR]
OR • D
Sponsored 10/23/2025
John Hickenlooper
CO • D
Sponsored 10/23/2025
Sen. Wyden, Ron [D-OR]
OR • D
Sponsored 10/23/2025
Sen. Heinrich, Martin [D-NM]
NM • D
Sponsored 10/23/2025
Amy Klobuchar
MN • D
Sponsored 10/23/2025
Sen. Fetterman, John [D-PA]
PA • D
Sponsored 10/23/2025
Sen. Kelly, Mark [D-AZ]
AZ • D
Sponsored 10/23/2025
Sen. Markey, Edward J. [D-MA]
MA • D
Sponsored 10/23/2025
Sen. Gallego, Ruben [D-AZ]
AZ • D
Sponsored 10/23/2025
Sen. Warren, Elizabeth [D-MA]
MA • D
Sponsored 10/23/2025
Peter Welch
VT • D
Sponsored 10/23/2025
Sen. Booker, Cory A. [D-NJ]
NJ • D
Sponsored 10/23/2025
Sen. Bennet, Michael F. [D-CO]
CO • D
Sponsored 10/27/2025
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov